Defined terms — Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products
European Union · 32000R0141 · 113 provisions
4 defined in this instrument, 2 borrowed from other acts.
Agency — the European Agency for the Evaluation of Medicinal Products (d)
clinical superiority — borrowed from another act; this instrument states no meaning of its own 4.
medicinal product — a medicinal product for human use, as defined in Article 2 of Directive 65/65/EEC (a)
orphan medicinal product — a medicinal product designated as such under the terms and conditions of this Regulation (b)
similar medicinal product — borrowed from another act; this instrument states no meaning of its own 4.
sponsor — any legal or natural person, established in the Community, seeking to obtain or having obtained the designation of a medicinal product as an orphan medicinal product (c)